[1]于晓然,温桥生,肖漪,等.阻断乳腺癌细胞PD-L1减弱对共培养树突状细胞成熟的抑制作用[J].南方医科大学学报,2018,(05):561.
点击复制

阻断乳腺癌细胞PD-L1减弱对共培养树突状细胞成熟的抑制作用()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2018年05期
页码:
561
栏目:
出版日期:
2018-05-15

文章信息/Info

Title:
Blocking programmed death-ligand 1 attenuates maturation inhibition of dendritic cells by co-cultured breast cancer cells
作者:
于晓然温桥生肖漪唐芮李福喜邵文凤余焱林熊静波
关键词:
乳腺癌PD-L1PD-1树突状细胞成熟肿瘤治疗肿瘤微环境
Keywords:
breast cancer programmed death- ligand 1 programmed from cell death protein 1 dendritic cell maturation cancer therapy cancer microenvironment
摘要:
目的探讨表达PD-L1的乳腺癌细胞是否通过激活树突状细胞的PD-L1/PD-1信号通路抑制树突状细胞成熟。方法人单 核细胞用GM-CSF和IL-4诱导为不成熟树状突细胞,再用TNF-α诱导为成熟树状突细胞;表达PD-L1的乳腺癌细胞系MDAMB- 231与树状突细胞接触共培养;PD-L1阻断抗体处理共培的的乳腺癌细胞和树状突细胞;重组人PD-L1蛋白处理TNF-α诱 导的树突状细胞;流式细胞仪检测乳腺癌细胞膜PD-L1的表达和树突状细胞的成熟分化标志HLA-DR和CD83。结果乳腺癌 细胞MDA-MB-231细胞系中,细胞膜表面PD-L1阳性细胞高达(99.7±0.15)%;HLA-DR和CD83阳性细胞在成熟树状突细胞对 照组分别为(88.8±6.96)%和(18.36±3.07)%,在MDA-MB-231共培养实验组树状突细胞群分别降至(42.76±10.52)%和(9.93± 2.74)%,两组比较差异有统计学意义(P<0.01,P<0.05);HLA-DR和CD83 阳性细胞在PD-L1 抗体同型对照组分别为(45.17± 10.19)%和(10.15±2.54)%,在PD-L1抗体处理组分别升至(63.46±1.72)%和(16.46±2.58)%,两组相比差异均有统计学意义(P< 0.05);和成熟树状突细胞对照组相比,人重组PD-L1蛋白处理组HLA-DR和CD83阳性细胞率较低,组间统计学差异有统计学 意义(P<0.05)。结论PD-L1抗体对三阴性乳腺癌患者的治疗的效果,可能部分基于抗体阻断乳腺癌细胞表面的PD-L1,从而 减弱其对肿瘤微环境中的树突状细胞成熟的抑制作用。
Abstract:
Objective To study if programmed death- ligand 1 (PL-L1) expression in breast cancer cell activates PD-L1/PD- 1 pathway in dendritic cells to inhibit dendritic cell maturation. Methods Human monocytes were induced to differentiate into immature dendritic cells using GM-CSF and IL-4, and further to mature dendritic cells using TNF-α. PD-L1-expressing breast cancer cell line MDA-MB-231 was co-cultured in contact with the dendritic cells to observe the effects of the breast cancer cells on the maturation of the dendritic cells. A PD-L1 blocking antibody was applied to the co- culture, and the changes in the inhibitory effect of the MDA-MB-231 cells on dendritic cell maturation was observed. TNF- α- induced dendritic cells were treated with a recombinant human PD-L1 protein to study the effect of PD-L1/PD-1 pathway activation on the maturation of dendritic cells. The expression of PD-L1 in MDA-MB-231 cells and the dendritic cell maturation marker HLA-DR and CD83 were analyzed using flow cytometry. Results MDA-MB-231 cell line showed PD-L1 positivity on the cell membrane cells at a rate as high as (99.7±0.15)%. In mature dendritic cells, the positivity rates for HLA-DR and CD83 were (88.8±6.96)% and (18.36± 3.07)% , respectively, but in the co-culture system, the positivity rates of the dendritic cells were significantly decreased to (42.76±10.52)% (P<0.01) and (9.93±2.74)% (P<0.05), respectively, indicating that MDA-MB-231 cells inhibited the maturation of dendritic cells. Following treatment with a PD-L1 antibody isotype control, the percentages of HLA-DR- and CD83-positive cells in the co-culture were (45.17±10.19)% and (10.15±2.54)%, which were significantly increased to (63.46±1.72)% and (16.46± 2.58)% after treatment with PD-L1 antibody, respectively (both P<0.05). Compared with the mature dendritic cell controls, the cells treated with the recombinant human PD- L1 protein exhibited significantly lowered percentages of HLA- DR- positive [from (84.23±4.18)% to (2.56±2.39)%, P<0.05] and CD83-positive cells [(87.26±1.54)% to (60.67±1.63)%, P<0.05]. Conclusion The effect of PD-L1 antibody therapy on triple negative breast cancer can be partially mediated by blocking PD-L1 expression on breast cancer cell membrane, which attenuates the inhibition of dendritic cell maturation in the cancer microenvironment.

相似文献/References:

[1]黄伟斌,姚广裕,刘民锋,等.心肌钙蛋白I 对蒽环类化疗的乳腺癌患者心脏毒性的预测价值[J].南方医科大学学报,2011,(06):1047.
[2]郭启帅,黄曦,李少林.沉默PeroxiredoxinⅠ基因对乳腺癌裸鼠移植瘤放射敏感性的影响[J].南方医科大学学报,2011,(07):1119.
[3]冯云,周会行,李军红,等.肝癌缺失基因1和磷酸化粘着斑激酶蛋白在乳腺癌组织中的表达及意义[J].南方医科大学学报,2011,(08):1448.
[4]夏青,史艳侠,刘东耕,等.一项单中心的25例男性乳腺癌临床病理特点总结[J].南方医科大学学报,2011,(09):1469.
[5]李嗣杰,贾泓瑶,吴迪,等.肿瘤翻译调控蛋白在人乳腺癌组织中的表达及临床意义[J].南方医科大学学报,2011,(09):1560.
[6]马吉光,王宁菊,于文洁.“三阴”型与非“三阴”型乳腺癌患者的生物学行为差异性分析[J].南方医科大学学报,2011,(10):1729.
[7]王玲,单保恩,桑梅香,等.靶向沉默p65 基因对人乳腺癌细胞MDA-MB-231增殖及凋亡的影响[J].南方医科大学学报,2011,(10):1742.
[8]陈可和,梁博,邹镇洪,等.Rheb和Rheb’D60K突变基因重组慢病毒载体的构建、鉴定及其对肝癌细胞凋亡的影响[J].南方医科大学学报,2012,(03):341.
[9]胡孝渠,秦利,苏逢锡,等.载体介导HER-2RNA干扰治疗乳腺癌研究[J].南方医科大学学报,2006,(05):570.
 HU Xiao-qu,QIN Li,SU Feng-xi,et al.Vector-mediated HER-2 RNA interference against HER-2-positive breast cancer[J].Journal of Southern Medical University,2006,(05):570.
[10]王晓冰,杨清绪,裴小娟,等.乳腺浸润性癌血管生成相关因子的表达及其临床意义[J].南方医科大学学报,2006,(06):860.
 WANG Xiao-bing,YANG Qing-xu,PEI Xiao-juan Department of Pathology,et al.Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance[J].Journal of Southern Medical University,2006,(05):860.

更新日期/Last Update: 1900-01-01